{"url_path":"/sec/xtnt/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1453593/0001493152-26-022604-index.html","accession_number":"0001493152-26-022604","cik":"0001453593","ticker":"XTNT","issuer_name":"Xtant Medical Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1453593/0001493152-26-022604-index.html","primary_entity_key":"0001453593","primary_entity_name":"Xtant Medical Holdings, Inc."},"word_count":65,"has_tables":true,"body_markdown":"**ITEM\n5.**\n**Other\nInformation**\n\n \n\n**Rule\n10b5-1 Plan and Non-Rule 10b5-1 Trading Arrangement Adoptions, Terminations, and Modifications**\n\n \n\nDuring\nthe three months ended March 31, 2026, none of our directors or “officers” (as defined in Rule 16a-1(f) under the Exchange\nAct) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each\nterm is defined in Item 408 of SEC Regulation S-K.\n\n \n\n24"}